THURSDAY, SEPTEMBER 21, 2017

Rhode Island doctor creates Ebola diagnostic tool

An emergency medicine physician who works at Rhode Island Hospital and The Miriam Hospital has used his experience treating Ebola patients in Liberia in 2014 to create a new diagnostic tool for the Ebola virus. Read More »

North American birds contract and spread highly contagious avian flu

Recent analysis shows North America birds have contracted and spread highly contagious strains of avian influenza (HPAI) H5 viruses that originated in Eurasia and continue to spread around the world. Read More »

Case Western Reserve to head international research of TB-resistant individuals

Case Western Reserve University instructors have discovered a group of people uniquely immune to tuberculosis (TB) infections and will lead an international research effort to understand how these individuals are TB-resistant. Read More »

Duke researchers receive grants for HIV vaccine studies

Researchers at Duke Medicine in North Carolina recently accepted a large, multi-year federal grant from the National Institutes of Health (NIH) for their projects to develop HIV vaccines. Read More »

Model shows HIV spreads like Internet malware

A novel model that illustrates HIV's progression shows the virus spreads in ways similar to Internet malware, proving that early treatment is crucial to preventing AIDS. Read More »

Gates Foundation names Emini director of HIV for Global Health

Chief scientific officer at Pfizer also has served as senior adviser to foundation's HIV team Read More »

RSV severity increases with genetic variant and environmental factors

An international team of scientific investigators has discovered that combining a specific gene mutation with an urban environment increases the chance that children will contract severe infections of respiratory syncytial virus (RSV). Read More »

Pfizer taps Jansen to lead R&D programs for vaccines

Kathrin U. Jansen is new senior vice president of the Vaccine Research and Development Unit Read More »

Sudan measles outbreak lacks sufficient funding and vaccines

The Ministry of Health of Sudan, UNICEF, the World Health Organization (WHO) and other organizations have participated in the response to Sudan’s measles outbreak, but they report that they lack the necessary funding and vaccines to adequately treat the outbreak. Read More »

VBI Vaccines and Sanofi Pasteur partner to increase vaccine stability

According to a recent announcement from VBI Vaccines Inc., VBI has partnered with Sanofi Pasteur to improve the stability of vaccines. Read More »

Park City, Utah sees whooping cough outbreak

Summit County Health Department reports 62 to 63 cases in children Read More »

Tech Council of Maryland summit to advance vaccines and treatments

The Tech Council of Maryland (TCM), the largest technology trade association in Maryland, has announced that it will emphasize the role Maryland has had in creating and developing cancer treatments and lifesaving vaccines during The Atlantic Vaccines and Immunotherapeutics Summit May 7-8. Read More »

Mummified bodies show TB's impact on 18th-century Europe

Researchers recently discovered mummified bodies in a Hungarian crypt that show scientists how deeply tuberculosis (TB) impacted Europe during the 18th century, a finding that could crucially impact future diagnosis and control methods for TB. Read More »

Louisiana health department opens public health laboratory

The Louisiana Department of Health and Hospitals (DHH) celebrated as it recently opened the public health laboratory in Baton Rouge, a part of Louisiana’s response to public health concerns such as food borne illnesses, radiation events and Ebola, among other issues. Read More »

Officials give update on southeastern Indiana HIV outbreak

Indiana State Department of Health (ISDH) officials provided an update this week about the HIV outbreak taking place in southeastern Indiana. Read More »

ADPH assists Alabama State University in TB investigation

The Alabama Department of Public Health (ADPH) is assisting Alabama State University in the investigation concerning tuberculosis (TB) cases. Read More »

Merck receives FDA Breakthrough Therapy designations for HCV treatment

Merck, commonly called MSD outside the US and Canada, recently announced that it has received Breakthrough Therapy designation from the United States Food and Drug Administration (FDA) for the company’s grazoprevir/elbasvir investigational single tablet regimen to treat chronic hepatitis C virus (HCV) infections. Read More »

Rockefeller's first human HIV antibody therapy study shows hopeful results

Rockefeller University researchers recently released the results of their HIV antibody therapy study, which was the first to involve human subjects. Read More »

Merck's grazoprevir/elbasvir therapy receives FDA designations

Merck Research Laboratories' grazoprevir/elbasvir therapy has received two new Breakthrough Therapy designations from the Food and Drug Administration, reflecting encouraging news for patients with Hepatitis C virus (HCV), chronic kidney disease, cirrhosis or HIV co-infection. Read More »

UTMB researchers create single-dose Ebola vaccine

Researchers from the University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. have created an Ebola vaccine that is safe, fast-acting, effective and requires only a single dose. Read More »